Trial Profile
A study to evaluate patient adherence and utilization patterns of sofosbuvir based regimens
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jun 2016
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary) ; Sofosbuvir (Primary) ; Peginterferon; Ribavirin; Simeprevir
- Indications Hepatitis C
- Focus Therapeutic Use
- 02 Jun 2016 New trial record
- 25 May 2016 Results presented at the 21st Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research